Hu Fang-Yuan, Li Jian-Kang, Gao Feng-Juan, Qi Yu-He, Xu Ping, Zhang Yong-Jin, Wang Dan-Dan, Wang Lu-Sheng, Li Wei, Wang Min, Chen Fang, Shen Si-Mai, Xu Ge-Zhi, Zhang Sheng-Hai, Chang Qing, Wu Ji-Hong
Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China.
State Key Laboratory of Medical Neurobiology, Institutes of Brain Science and Collaborative Innovation Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China.
Front Genet. 2019 Sep 5;10:773. doi: 10.3389/fgene.2019.00773. eCollection 2019.
To clarify the mutation spectrum and frequency of in a Chinese cohort with Stargardt disease (STGD1). A total of 153 subjects, comprising 25 families (25 probands and their family members) and 71 sporadic cases, were recruited for the analysis of variants. All probands with STGD1 underwent a comprehensive ophthalmologic examination. Overall, 792 genes involved in common inherited eye diseases were screened for variants by panel-based next-generation sequencing (NGS). Variants were filtered and analyzed to evaluate possible pathogenicity. The total variant detection rate of at least one mutant allele was 84.3% (129/153): two or three disease-associated variants in 86 subjects (56.2%), one mutant allele in 43 subjects (28.1%), and no variants in 24 subjects (15.7%). Ninety-six variants were identified in the total cohort, which included 62 missense (64%), 15 splicing (16%), 11 frameshift (12%), 6 nonsense (6%), and 2 small insertion or deletion (2%) variants. Thirty-seven novel variants were found, including a variant, c.4561delA. The most prevalent variant was c.101_106delCTTTAT (10.5%), followed by c.2894A > G (6.5%) and c.6563T > C (4.6%), in STGD1 patients from eastern China. Thirty-seven novel variants were detected using panel-based NGS, including one variant, further extending the mutation spectrum of . The common variants in a population from eastern China with STGD1 were also identified.
为明确中国人群中Stargardt病(STGD1)患者的突变谱及突变频率。共招募了153名受试者,包括25个家系(25名先证者及其家庭成员)和71例散发病例,用于分析ABCA4基因变异。所有STGD1先证者均接受了全面的眼科检查。总体而言,通过基于基因panel的二代测序(NGS)对792个常见遗传性眼病相关基因进行了变异筛查。对变异进行过滤和分析以评估其可能的致病性。至少一个ABCA4突变等位基因的总变异检出率为84.3%(129/153):86名受试者(56.2%)存在两个或三个疾病相关变异,43名受试者(28.1%)存在一个突变等位基因,24名受试者(15.7%)未检测到变异。在整个队列中鉴定出96个变异,其中包括62个错义变异(64%)、15个剪接变异(16%)、11个移码变异(12%)、6个无义变异(6%)和2个小插入或缺失变异(2%)。发现了37个新变异,包括一个ABCA4变异,即c.4561delA。在中国东部的STGD1患者中,最常见的变异是c.101_106delCTTTAT(10.5%),其次是c.2894A>G(6.5%)和c.6563T>C(4.6%)。通过基于基因panel的NGS检测到37个新变异,包括一个ABCA4变异,进一步扩展了ABCA4的突变谱。同时也确定了中国东部人群中STGD1患者的常见变异。